ESR(01821.HK)联席首席执行官增购股权至10.45%
ESR(01821.HK)公布,根据其获提供的资料,Laurels Capital Investments已就向WP OCIM收购3,000万股公司股份,占公司已发行股本约0.98%及有关公司股份的389.99万份购股权的买卖协议。集团之执行董事、联合创始人兼联席首席执行官沈晋初於买方所持股份中拥有视作权益,原因为买方由The Shen Trust全资拥有而沈氏为The Shen Trust的委托人的唯一股东。
收购事项完成後,沈氏将拥有3.2亿股公司股份的权益,包括已发行股份及根据一级雇员持股计划所涉及的股份相关购股权,合计占公司已发行股本约10.45%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.